• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store

Labs Partner with Pharma Companies to Develop New CDx Tests

by Glenn S. Demby | Jan 31, 2023 | Deals-lir, Essential, Laboratory Industry Report

There were three notable CDx alliances announced in January 2023, all of which involved cancer-related solutions.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Guardant Health Leads Wave of New Cancer Diagnostics Collaborations

Guardant Health Leads Wave of New Cancer Diagnostics Collaborations

by Glenn S. Demby | Jan 4, 2023 | Deals-lir, Essential, Laboratory Industry Report

Deals involving the development and commercialization of new cancer diagnostics and treatments were the most common in December.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Amazon Makes Third Attempt to Disrupt Healthcare Business

Amazon Makes Third Attempt to Disrupt Healthcare Business

by Glenn S. Demby | Dec 1, 2022 | Deals-lir, Essential, Laboratory Industry Report

Having twice failed to disrupt health care, Amazon opts for a different strategy this time around—and it may just work.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Getlabs Continues In-Home Phlebotomy Services Advance

Getlabs Continues In-Home Phlebotomy Services Advance

by Glenn S. Demby | Oct 31, 2022 | Deals-lir, Essential, Laboratory Industry Report

The Miami-based startup has secured major in-home phlebotomy services contracts from some of the nation’s biggest lab companies.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Qiagen Moves into Neurology with Recent Collaboration

Qiagen Moves into Neurology with Recent Collaboration

by Glenn S. Demby | Sep 30, 2022 | Deals-lir, Essential, Laboratory Industry Report

The Hilden, Germany-based company is extending its genetic testing profile beyond oncology to neurology biomarkers.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com